Results of International Mesenchymal Stem Cell Trial Suggest No Benefits Against Inflammation in Active MS
November 4, 2021 Results have been published from a phase 2 clinical trial conducted at 15 sites in 9 countries,…
Important Patient and Consumer Information About Regenerative Medicine Therapies / Diseases and Conditions not yet approved for this therapy
June 3, 2021 The US Food and Drug Administration (FDA) regulates regenerative medicine products. There continues to be broad…
Stuart Schlossman
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies
By DocWire News Featured Reading -July 24, 2021 ABSTRACT Currently, there is still no cure for multiple sclerosis (MS), which…
Stuart Schlossman
Cutting-edge multiple sclerosis treatment at Northwestern restores local college student’s vision, balance and energy: ‘I am a new person,’ says 22-year-old Ivy Marcucci
By NARA SCHOENBERG CHICAGO TRIBUNE | MAY 13, 2021 ====================== Ivy Marcucci can stand on one leg, with the other…
Stuart Schlossman
Researchers from Italy Report Long-Term Outcomes from Bone Marrow Transplants (aHSCT) to Treat MS
Click HERE to Subscribe for the MS Beacon Newsletter=========================== National MS Society article: January 20, 2021 Researchers from across Italy…
Stuart Schlossman
Expert analysis: Treating MS with autologous hematopoietic stem cell transplant
January 13, 2021 Click HERE to Subscribe for the MS Beacon Newsletter Tanuja Chitnis, MD, senior neurologist at Brigham and…
Stuart Schlossman
Hadassah and NeuroGenesis Announce Groundbreaking Results From Phase 2 MS Study
Click HERE to Subscribe for the MS Beacon Newsletter A Phase 2 study at Hadassah Hospital Ein Kerem has revealed…
Stuart Schlossman
National MS Society Releases Recommendations for aHSCT-Bone Marrow Transplant for MS
_______________________________________ Click HERE to Subscribe for the MS Beacon Newsletter November 11, 2020 The National Medical Advisory Committee of the National MS…
Stuart Schlossman
Update: National MS Society issues guidance on autologous hematopoietic stem cell transplant
Autologous hematopoietic stem cell transplant represents “a useful treatment option” for patients with relapsing MS who experience breakthrough disease activity…
Stuart Schlossman
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Click HERE to Subscribe for the MS Beacon Newsletter Aaron E. Miller, MD1; Tanuja Chitnis, MD2; Bruce A. Cohen, MD3; et alKathleen Costello, MS, CRNP, MSCN4; Nancy L. Sicotte, MD5; Rachael Stacom, MS, ANP-BC, MSCN6; and the National…
Stuart Schlossman
